REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 68 filers reported holding REDHILL BIOPHARMA LTD in Q4 2020. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,000 | -82.0% | 10,000 | -50.0% | 0.00% | – |
| Q1 2022 | $50,000 | -3.8% | 20,000 | 0.0% | 0.00% | – |
| Q4 2021 | $52,000 | -67.7% | 20,000 | -9.1% | 0.00% | – |
| Q1 2021 | $161,000 | -11.0% | 22,000 | -1.6% | 0.00% | – |
| Q4 2020 | $181,000 | -20.6% | 22,355 | 0.0% | 0.00% | – |
| Q3 2020 | $228,000 | -22.2% | 22,355 | -49.0% | 0.00% | – |
| Q2 2020 | $293,000 | +90.3% | 43,800 | +28.8% | 0.00% | – |
| Q1 2020 | $154,000 | -25.2% | 34,001 | +0.0% | 0.00% | – |
| Q4 2019 | $206,000 | +71.7% | 34,000 | +100.0% | 0.00% | – |
| Q3 2019 | $120,000 | +8.1% | 17,000 | 0.0% | 0.00% | – |
| Q2 2019 | $111,000 | -21.3% | 17,000 | 0.0% | 0.00% | – |
| Q1 2019 | $141,000 | +110.4% | 17,000 | +41.7% | 0.00% | – |
| Q4 2018 | $67,000 | -36.8% | 12,000 | 0.0% | 0.00% | – |
| Q3 2018 | $106,000 | +3.9% | 12,000 | -0.0% | 0.00% | – |
| Q2 2018 | $102,000 | +64.5% | 12,001 | 0.0% | 0.00% | – |
| Q1 2018 | $62,000 | 0.0% | 12,001 | +0.0% | 0.00% | – |
| Q4 2017 | $62,000 | -52.3% | 12,000 | 0.0% | 0.00% | – |
| Q3 2017 | $130,000 | +26.2% | 12,000 | -0.0% | 0.00% | – |
| Q2 2017 | $103,000 | +2.0% | 12,005 | +13.6% | 0.00% | – |
| Q1 2017 | $101,000 | – | 10,565 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |